[1]Patent:WO2009/150497,2009,A1,.Locationinpatent:Page/Pagecolumn9
[2]Pharmazie,1987,vol.42,#3,p.162-164
[3]JournaloftheAmericanChemicalSociety,1960,vol.82,p.1161-1166
[4]JournalofOrganicChemistry,1960,vol.25,p.970-981
[5]JournaloftheAmericanChemicalSociety,1960,vol.82,p.1132-1135
[6]JournalofOrganicChemistry,1961,vol.26,p.3842-3850
[7]JournalfuerPraktischeChemie(Leipzig),1962,vol.16,p.264-276
[8]Patent:WO2007/26376,2007,A2,.Locationinpatent:Page/Pagecolumn7
[9]Patent:WO2007/26376,2007,A2,.Locationinpatent:Page/Pagecolumn8
[10]Patent:WO2007/26376,2007,A2,.Locationinpatent:Page/Pagecolumn8
[11]Patent:CN103396381,2016,B,.Locationinpatent:Paragraph0027-0030
[12]Patent:CN105272937,2016,A,.Locationinpatent:Paragraph0014-0015
[13]Tetrahedron,2018,vol.74,#51,p.7237-7241
[1]JournalofOrganicChemistry,1961,vol.26,p.3842-3850
[2]JournalfuerPraktischeChemie(Leipzig),1962,vol.16,p.264-276
[1]Cragoe,E.J.etal.[Journalofmedicinalandpharmaceuticalchemistry,1962,vol.5,p.896-912]
[2]Ravina;Montanes;Cobreros;Tato[Chimicatherapeutica,1973,vol.8,#3,p.290-296]
[1]CurrentPatentAssignee:ALEMBICLTD-WO2009/150497,2009,A1Locationinpatent:Page/Pagecolumn9
[2]Henning;Scholz;Wolf[Pharmazie,1987,vol.42,#3,p.162-164]
[3]Werner,L.H.etal.[JournaloftheAmericanChemicalSociety,1960,vol.82,p.1161-1166]
[4]Novello,F.C.etal.[JournalofOrganicChemistry,1960,vol.25,p.970-981]
[5]Close,W.J.etal.[JournaloftheAmericanChemicalSociety,1960,vol.82,p.1132-1135]
[6]Topliss,J.G.etal.[JournalofOrganicChemistry,1961,vol.26,p.3842-3850]
[7]Klosa,J.;Voigt,H.[JournalfurpraktischeChemie(Leipzig1954),1962,vol.16,p.264-276]
[8]CurrentPatentAssignee:UNICHEMLABORATORIESLIMITED-WO2007/26376,2007,A2Locationinpatent:Page/Pagecolumn7
[9]CurrentPatentAssignee:UNICHEMLABORATORIESLIMITED-WO2007/26376,2007,A2Locationinpatent:Page/Pagecolumn8
[10]CurrentPatentAssignee:UNICHEMLABORATORIESLIMITED-WO2007/26376,2007,A2Locationinpatent:Page/Pagecolumn8
[11]CurrentPatentAssignee:ANYANGJIUZHOUPHARMACEUTICAL-CN103396381,2016,BLocationinpatent:Paragraph0027-0030
[12]CurrentPatentAssignee:CHANGZHOUPHARMACEUTICALFACTORYCO.,LTD.-CN105272937,2016,ALocationinpatent:Paragraph0014-0015
[13]Kitanosono,Taku;Cho,SooMin;Kobayashi,Shū[Tetrahedron,2018,vol.74,#51,p.7237-7241]
[1]JournalofOrganicChemistry,1961,vol.26,p.2809-2813
[1]Whitehead,C.W.etal.[JournalofOrganicChemistry,1961,vol.26,p.2814-2818]
[1]Journalofmedicinalandpharmaceuticalchemistry,1962,vol.5,p.896-912
Title: Molecular cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Malassezia globosa, a potential antidandruff target.
Journal: Journal of medicinal chemistry 20120412
Title: Mutation of active site residues Asn67 to Ile, Gln92 to Val and Leu204 to Ser in human carbonic anhydrase II: influences on the catalytic activity and affinity for inhibitors.
Journal: Bioorganic & medicinal chemistry 20120401
Title: Cloning, characterization and sulfonamide inhibition studies of an α-carbonic anhydrase from the living fossil sponge Astrosclera willeyana.
Journal: Bioorganic & medicinal chemistry 20120215
Title: Inhibition studies of the β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates.
Journal: Bioorganic & medicinal chemistry 20110815
Title: A new β-carbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth.
Journal: Bioorganic & medicinal chemistry 20110201
Title: Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata.
Journal: Bioorganic & medicinal chemistry letters 20110115
Title: Mutation of Phe91 to Asn in human carbonic anhydrase I unexpectedly enhanced both catalytic activity and affinity for sulfonamide inhibitors.
Journal: Bioorganic & medicinal chemistry 20100801
Title: 3D-QSAR study of benzene sulfonamide analogs as carbonic anhydrase II inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20100515
Title: Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Brucella suis.
Journal: Journal of medicinal chemistry 20100311
Title: Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c.
Journal: Bioorganic & medicinal chemistry letters 20091201
Title: Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides.
Journal: Bioorganic & medicinal chemistry 20090715
Title: Carbonic anhydrase inhibitors. Inhibition and homology modeling studies of the fungal beta-carbonic anhydrase from Candida albicans with sulfonamides.
Journal: Bioorganic & medicinal chemistry 20090701
Title: Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis.
Journal: Journal of medicinal chemistry 20090514
Title: Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate.
Journal: Journal of medicinal chemistry 20090423
Title: Carbonic anhydrase inhibitors. Biphenylsulfonamides with inhibitory action towards the transmembrane, tumor-associated isozymes IX possess cytotoxic activity against human colon, lung and breast cancer cell lines.
Journal: Journal of enzyme inhibition and medicinal chemistry 20090401
Title: Detection of urinary markers for thiazide diuretics after oral administration of hydrochlorothiazide and altizide-relevance to doping control analysis.
Journal: Journal of chromatography. A 20090320
Title: A novel class of allosteric modulators of AMPA/Kainate receptors.
Journal: Bioorganic & medicinal chemistry letters 20090215
Title: Carbonic anhydrase inhibitors: inhibition of the beta-class enzyme from the yeast Saccharomyces cerevisiae with sulfonamides and sulfamates.
Journal: Bioorganic & medicinal chemistry 20090201
Title: Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides.
Journal: Bioorganic & medicinal chemistry 20071201
Title: Carbonic anhydrase inhibitors: inhibition of human, bacterial, and archaeal isozymes with benzene-1,3-disulfonamides--solution and crystallographic studies.
Journal: Bioorganic & medicinal chemistry letters 20070801
Title: Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20070701
Title: Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.
Journal: Journal of medicinal chemistry 20070125
Title: Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.
Journal: Bioorganic & medicinal chemistry letters 20060415
Title: QSAR study on topically acting sulfonamides incorporating GABA moieties: a molecular connectivity approach.
Journal: Bioorganic & medicinal chemistry letters 20060401
Title: Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.
Journal: Journal of medicinal chemistry 20060323
Title: Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors.
Journal: Journal of medicinal chemistry 20051201
Title: Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides.
Journal: Bioorganic & medicinal chemistry letters 20050901
Title: Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?
Journal: Bioorganic & medicinal chemistry letters 20050215
Title: Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.
Journal: Bioorganic & medicinal chemistry letters 20050215
Title: Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides.
Journal: Bioorganic & medicinal chemistry letters 20050215
Title: Carbonic anhydrase inhibitors. Inhibition of the prokariotic beta and gamma-class enzymes from Archaea with sulfonamides.
Journal: Bioorganic & medicinal chemistry letters 20041220
Title: Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives.
Journal: Bioorganic & medicinal chemistry letters 20041115
Title: Carbonic anhydrase inhibitors: the first QSAR study on inhibition of tumor-associated isoenzyme IX with aromatic and heterocyclic sulfonamides.
Journal: Bioorganic & medicinal chemistry letters 20040621
Title: Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides.
Journal: Bioorganic & medicinal chemistry letters 20030324
Title: Mass spectrometric behavior of thiazide-based diuretics after electrospray ionization and collision-induced dissociation.
Journal: Analytical chemistry 20020801
Title: Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties.
Journal: Journal of medicinal chemistry 20020328
Title: Isolation of a 2:1 hydrochlorothiazide-formaldehyde adduct impurity in hydrochlorothiazide drug substance by preparative chromatography and characterization by electrospray ionization LC-MS.
Journal: Journal of pharmaceutical and biomedical analysis 20011101
Title: Carbonic anhydrase inhibitors: synthesis of sulfonamides incorporating dtpa tails and of their zinc complexes with powerful topical antiglaucoma properties.
Journal: Bioorganic & medicinal chemistry letters 20010226
